Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q1 2023 | 2023-04-21 | Future report Set alerts | |
Q4 2022 | 2023-01-27 | 4.64 | 4.64 |
Q3 2022 | 2022-10-21 | 3.93 | 3.93 |
Q2 2022 | 2022-07-22 | 4.21 | 4.21 |
Q1 2022 | 2022-04-22 | 4.12 | 4.12 |
Q4 2021 | 2022-01-27 | 4.42 | 4.42 |
Q3 2021 | 2021-10-22 | 4.57 | 4.57 |
Q2 2021 | 2021-07-20 | 4.37 | 4.37 |
Q1 2021 | 2021-04-22 | 4.14 | 4.14 |
Q4 2020 | 2021-02-02 | 4.13 | 4.13 |
2016-06-28 | Reiterated Rating | Credit Suisse | Buy | |
2016-06-28 | Reiterated Rating | Credit Suisse Group AG | Buy | |
2016-06-16 | Initiated Coverage | Sanford C. Bernstein | Market Perform | $88.00 |
2016-06-01 | Downgrade | Longbow Research | Outperform to Market Perform | $74.00 |
2016-06-01 | Downgrade | Leerink Swann | Outperform to Mkt Perform | |
2016-06-01 | Lower Price Target | Barclays | Overweight | $80.00 to $79.00 |
2016-06-01 | Lower Price Target | Barclays PLC | Overweight | $80.00 to $79.00 |
2016-05-16 | Reiterated Rating | Robert W. Baird | Buy | |
2016-05-16 | Reiterated Rating | Sterne Agee CRT | Buy | |
2016-05-05 | Reiterated Rating | Credit Suisse | Buy | $90.00 |
2016-05-05 | Reiterated Rating | JPMorgan Chase & Co. | Buy | $85.00 |
2016-05-05 | Reiterated Rating | Jefferies Group | Buy | $94.00 |
2016-05-04 | Reiterated Rating | RBC Capital | Outperform | $86.00 to $89.00 |
2016-05-04 | Reiterated Rating | Oppenheimer | Buy | |
2016-05-04 | Reiterated Rating | Bank of America | Buy | $92.00 |
2016-05-04 | Reiterated Rating | Cantor Fitzgerald | Buy | |
2016-05-04 | Reiterated Rating | Wedbush | Outperform | $88.00 to $90.00 |
2016-05-04 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | |
2016-05-04 | Reiterated Rating | Bank of America Corp. | Buy | $92.00 |
2016-05-04 | Reiterated Rating | Royal Bank Of Canada | Outperform | $86.00 to $89.00 |
2016-04-17 | Reiterated Rating | Avondale Partners | Buy | |
2016-04-15 | Boost Price Target | Avondale Partners | Market Outperform | $85.00 to $92.00 |
2016-03-24 | Boost Price Target | Credit Suisse | Outperform | $78.00 to $83.00 |
2016-03-19 | Reiterated Rating | Oppenheimer | Buy | |
2016-03-14 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $76.00 to $85.00 |
2016-02-01 | Boost Price Target | Mizuho | Buy | $80.00 to $102.00 |
2016-01-31 | Reiterated Rating | Cantor Fitzgerald | Buy | $95.00 |
2016-01-29 | Boost Price Target | Credit Suisse | $75.00 to $78.00 | |
2016-01-29 | Lower Price Target | RBC Capital | Outperform | $90.00 to $86.00 |
2016-01-28 | Reiterated Rating | Wedbush | Buy | $80.00 |
2016-01-19 | Lower Price Target | Oppenheimer | $100.00 to $85.00 | |
2016-01-11 | Reiterated Rating | Oppenheimer | Outperform | $100.00 |
2016-01-06 | Lower Price Target | Barclays | Overweight | $80.00 to $79.00 |
2016-01-06 | Downgrade | Longbow Research | Outperform to Market Perform | $74.00 |
2016-01-06 | Upgrade | Raymond James | Market Perform to Outperform | $95.00 |
2016-01-06 | Downgrade | Leerink Swann | Outperform to Market Perform | $79.00 to $74.00 |
2016-01-06 | Upgrade | Raymond James Financial Inc. | Market Perform to Outperform | $95.00 |
2016-01-04 | Downgrade | Wells Fargo | Outperform to Market Perform | |
2016-01-04 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform | |
2015-12-17 | Downgrade | Goldman Sachs | Buy to Neutral | $80.00 |
2015-12-17 | Reiterated Rating | Credit Suisse | Buy | |
2015-12-17 | Downgrade | Goldman Sachs Group Inc. | Buy to Neutral | $80.00 |
2015-12-16 | Initiated Coverage | Credit Suisse | Outperform to Outperform | $75.00 |
2015-10-28 | Reiterated Rating | Leerink Swann | Outperform | $95.00 to $79.00 |
2015-10-28 | Reiterated Rating | Cantor Fitzgerald | Buy | $105.00 to $95.00 |
2015-10-28 | Lower Price Target | Barclays | Overweight | $94.00 to $80.00 |
2015-10-28 | Reiterated Rating | RBC Capital | Outperform | $102.00 to $90.00 |
2015-10-22 | Lower Price Target | Mizuho | Buy | $86.00 to $80.00 |
2015-10-19 | Lower Price Target | Susquehanna | Positive | $108.00 to $88.00 |
2015-10-16 | Reiterated Rating | Oppenheimer | Buy | |
2015-10-15 | Lower Price Target | Bank of America | Buy | $110.00 to $95.00 |
2015-10-15 | Lower Price Target | Jefferies Group | Buy | $112.00 to $88.00 |
2015-10-15 | Lower Price Target | Oppenheimer | Outperform | $105.00 to $100.00 |
2015-10-15 | Boost Price Target | Mizuho | Buy | $86.00 to $103.00 |
2015-10-08 | Reiterated Rating | Barclays | Buy | $105.00 to $94.00 |
2015-10-02 | Initiated Coverage | Citigroup Inc. | Neutral | $82.00 |
2015-09-16 | Initiated Coverage | JPMorgan Chase & Co. | Neutral | $98.00 |
2015-08-14 | Reiterated Rating | Mizuho | Buy | $100.00 to $103.00 |
2015-08-10 | Reiterated Rating | Cantor Fitzgerald | Buy | $105.00 |
2015-08-10 | Reiterated Rating | Deutsche Bank | Buy | $103.00 |
2015-08-10 | Reiterated Rating | Deutsche Bank AG | Buy | $103.00 |
2015-08-06 | Reiterated Rating | Mizuho | Outperform | $100.00 |
2015-08-06 | Boost Price Target | Barclays | Overweight | $103.00 to $105.00 |
2015-08-06 | Reiterated Rating | RBC Capital | Outperform | $93.00 to $102.00 |
2015-07-31 | Reiterated Rating | Cantor Fitzgerald | Buy | $105.00 |
2015-07-16 | Reiterated Rating | Barclays | Overweight | $84.00 to $103.00 |
2015-07-16 | Reiterated Rating | Oppenheimer | Outperform | $102.00 to $105.00 |
2015-06-28 | Reiterated Rating | Oppenheimer | Buy | |
2015-06-26 | Reiterated Rating | Jefferies Group | Buy | $95.00 to $108.00 |
2015-06-26 | Boost Price Target | Oppenheimer | Outperform | $87.00 to $102.00 |
2015-06-26 | Upgrade | Wells Fargo & Co. | Market Perform to Outperform | $112.00 to $92.00 |
2015-06-26 | Boost Price Target | Mizuho | Buy | $89.00 to $100.00 |
2015-06-26 | Upgrade | Wells Fargo | Market Perform to Outperform | $112.00 to $92.00 |
2015-06-25 | Reiterated Rating | Leerink Swann | Buy | |
2015-06-24 | Boost Price Target | Leerink Swann | Outperform | $85.00 to $95.00 |
2015-06-10 | Initiated Coverage | Wedbush | Outperform | $93.00 |
2015-06-09 | Reiterated Rating | Jefferies Group | Buy | |
2015-06-05 | Reiterated Rating | Deutsche Bank | Buy | $90.00 |
2015-05-14 | Upgrade | Morgan Stanley | In-Line | $81.00 to $59.00 |
2015-05-07 | Boost Price Target | Leerink Swann | Outperform to Outperform | $80.00 to $85.00 |
2015-05-06 | Boost Price Target | Credit Suisse | Outperform | $81.00 to $84.00 |
2015-05-06 | Boost Price Target | Barclays | Buy | $81.00 to $84.00 |
2015-05-06 | Reiterated Rating | Oppenheimer | Outperform | $87.00 |
2015-05-06 | Boost Price Target | RBC Capital | Outperform | $88.00 to $93.00 |
2015-04-29 | Reiterated Rating | Cantor Fitzgerald | Buy | $88.00 |
2015-04-16 | Reiterated Rating | Deutsche Bank | Buy | $89.00 to $90.00 |
2015-04-16 | Boost Price Target | RBC Capital | Outperform | $85.00 to $88.00 |
2015-02-04 | Set Price Target | Oppenheimer | Buy | $87.00 |
2015-02-04 | Set Price Target | Credit Suisse | Buy | $81.00 |
2015-01-27 | Set Price Target | Deutsche Bank | Buy | $89.00 |
2015-01-12 | Set Price Target | Oppenheimer | Buy | $84.00 |
2015-01-12 | Set Price Target | Cantor Fitzgerald | Buy | $80.00 to $88.00 |
2015-01-12 | Boost Price Target | Mizuho | Buy | $78.00 to $85.00 |
2015-01-08 | Boost Price Target | Barclays | Overweight | $81.00 to $84.00 |
2015-01-08 | Boost Price Target | Credit Suisse | Outperform | $81.00 to $83.00 |
2015-01-05 | Boost Price Target | Deutsche Bank | Buy | $82.00 to $89.00 |
2014-12-18 | Initiated Coverage | Sterne Agee CRT | Buy | $96.00 |
2014-11-12 | Downgrade | Wells Fargo & Co. | Outperform to Market Perform | $70.00 to $64.00 |
2014-11-12 | Downgrade | Wells Fargo | Outperform to Market Perform | $70.00 to $64.00 |
2014-10-29 | Reiterated | UBS | Buy | $77 to $86 |
2014-10-29 | Boost Price Target | Barclays | Overweight | $75.00 to $81.00 |
2014-10-29 | Reiterated Rating | Citigroup Inc. | Buy | $84.00 to $86.00 |
2014-10-29 | Boost Price Target | Oppenheimer | Outperform | $74.00 to $84.00 |
2014-10-29 | Reiterated Rating | Credit Suisse | Outperform | $76.00 to $81.00 |
2014-10-28 | Boost Price Target | Mizuho | Buy | $75.00 to $78.00 |
2014-10-16 | Boost Price Target | RBC Capital | Outperform | $80.00 to $83.00 |
2014-10-16 | Boost Price Target | Robert W. Baird | Outperform | $76.00 to $95.00 |
2014-10-02 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $72.00 to $80.00 |
2014-09-12 | Initiated Coverage | Leerink Swann | Outperform | |
2014-09-09 | Reiterated Rating | Deutsche Bank | Buy | $72.00 to $82.00 |
2014-07-31 | Boost Price Target | RBC Capital | Outperform | $56.00 to $80.00 |
2014-07-31 | Boost Price Target | JPMorgan Chase & Co. | $60.00 to $72.00 | |
2014-07-30 | Reiterated Rating | Citigroup Inc. | Buy | $60.00 to $84.00 |
2014-07-30 | Reiterated Rating | Barclays | Overweight | $58.00 to $75.00 |
2014-07-30 | Boost Price Target | Oppenheimer | Outperform | $62.00 to $74.00 |
2014-07-30 | Boost Price Target | Mizuho | Buy | $60.00 to $75.00 |
2014-07-17 | Reiterated Rating | Raymond James | Outperform | $59.00 to $75.00 |
2014-07-17 | Reiterated Rating | Deutsche Bank | Buy | $60.00 to $68.00 |
2014-07-17 | Reiterated Rating | Morgan Stanley | Overweight | $65.00 to $67.00 |
2014-07-17 | Boost Price Target | Jefferies Group | $72.00 | |
2014-07-16 | Boost Price Target | Susquehanna | Positive | $60.00 to $64.00 |
2014-06-03 | Boost Price Target | Mizuho | Buy | $57.00 to $60.00 |
2014-06-03 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $58.00 to $60.00 |
2014-04-30 | Boost Price Target | Oppenheimer | Outperform | $55.00 to $62.00 |
2014-04-30 | Boost Price Target | Mizuho | Buy | $55.00 to $57.00 |
2014-03-31 | Initiated Coverage | Monness Crespi & Hardt | Buy | |
2014-02-05 | Boost Price Target | FBR & Co. | Outperform | $53.00 to $55.00 |
2014-01-14 | Boost Price Target | Susquehanna | $55.00 to $60.00 | |
2014-01-08 | Boost Price Target | Deutsche Bank | Buy | $56.00 to $58.00 |
2013-12-18 | Upgrade | Goldman Sachs | Conviction-Buy | |
2013-11-13 | Reiterated Rating | BMO Capital Markets | Market Perform | $43.00 to $44.00 |
2013-11-08 | Initiated Coverage | FBR & Co. | Outperform | $53.00 |
2013-11-06 | Boost Price Target | RBC Capital | Outperform | $49.00 to $54.00 |
2013-10-18 | Boost Price Target | CRT Capital | Buy | $49.00 to $57.00 |
2013-10-18 | Boost Price Target | Mizuho | Buy | $51.00 to $55.00 |
2013-10-15 | Boost Price Target | Susquehanna | Positive | $46.00 to $54.00 |
2013-10-08 | Initiated Coverage | Goldman Sachs | Buy | $50.00 to $46.26 |
2013-10-07 | Boost Price Target | Deutsche Bank | Buy | $46.00 to $56.00 |
2013-10-03 | Boost Price Target | Lazard Capital Markets | Buy | $48.00 to $52.00 |
2013-09-24 | Reiterated Rating | Barclays | Buy | $47.00 |
2013-09-24 | Boost Price Target | JPMorgan Chase & Co. | Overweight | $43.00 to $50.00 |
2013-09-18 | Upgrade | Mizuho | Neutral to Buy | $42.00 to $51.00 |
2013-02-06 | Reiterated | WallachBeth | Hold | $31 to $36 |
2013-01-18 | Reiterated | Mizuho | Neutral | $31 to $39 |
2012-11-26 | Reiterated | Robert W. Baird | Outperform | $37 to $35 |
2016-06-28 | Reiterated Rating | Credit Suisse | Buy | |
2016-06-28 | Reiterated Rating | Credit Suisse Group AG | Buy | |
2016-06-16 | Initiated Coverage | Sanford C. Bernstein | Market Perform | $88.00 |
2016-06-01 | Downgrade | Longbow Research | Outperform to Market Perform | $74.00 |
2016-06-01 | Downgrade | Leerink Swann | Outperform to Mkt Perform |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In HCA 587 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
Vanguard Group, Inc | 18.09M |
BlackRock Inc. | 14.84M |
WELLINGTON MANAGEMENT CO LLP | 14.00M |
Sanders Capital, LLC | 11.12M |
STATE STREET CORP | 9.16M |
BlackRock Institutional Trust Company, N.A. | 8.38M |
HARRIS ASSOCIATES L P | 7.54M |
PRICE T ROWE ASSOCIATES INC /MD/ | 5.31M |
FMR LLC | 4.61M |
First Eagle Investment Management, LLC | 4.50M |
BlackRock Fund Advisors | 4.25M |
JPMORGAN CHASE & CO | 4.11M |
GEODE CAPITAL MANAGEMENT, LLC | 3.74M |
BlackRock Group LTD | 3.38M |
FRANKLIN RESOURCES INC | 2.98M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
HERCULES HOLDING II, LLC | 17.29% (74776955) | HCA / |
PAGLIUCA STEPHEN G | 1.76% (7612921) | HCA / IT / |
JOHNSON R MILTON President & CEO | 0.24% (1033642) | HCA / |
WATERMAN ROBERT A SVP & General Counsel | 0.06% (254856) | HCA / |
KKR Millennium Fund L.P. | 0.05% (208507) | HCA / ROC / |
KKR PEI Investments, L.P. | 0.05% (208507) | HCA / KKR / |
KRAVIS HENRY R | 0.05% (208507) | FDC / HCA / KKR / |
CAMPBELL VICTOR L SVP | 0.04% (189868) | HCA / |
MOORE A BRUCE JR Group President - Service Line | 0.03% (127926) | HCA / |
ANDERSON DAVID GWIN SVP - Finance and Treasurer | 0.02% (101905) | HCA / |
Perlin Jonathan B Pres-Clinical Services & CMO | 0.02% (95115) | HCA / |
BRACKEN RICHARD M Chairman | 0.02% (82499) | CVS / HCA / |
RUTHERFORD BILL B CFO and EVP | 0.02% (72722) | HCA / |
STEELE JOHN M SVP - Human Resources | 0.02% (67741) | HCA / |
STEAKLEY JOSEPH N SVP-Internal Audit Services | 0.02% (65199) | HCA / |
Foster Jon M Group President | 0.02% (65054) | HCA / |
Hall Charles J Group President | 0.01% (63999) | HCA / |
Vallarino Juan SVP- Employer&Payer Engagement | 0.01% (61036) | HCA / |
Stinnett Donald W SVP & Controller | 0.01% (51965) | HCA / |
MEYERS GEOFFREY G | 0.01% (37743) | HCA / HCN / PMC / |
YUSPEH ALAN R SVP & Chief Ethics Officer | 0.01% (35546) | HCA / |
HAZEN SAMUEL N President - Operations | 0.01% (32237) | HCA / |
Light Jay O | 0.01% (30953) | BX / HCA / |
ROWE JOHN W | 0.01% (28978) | HCA / |
Davis Jana Joustra SVP - Corporate Affairs | 0.01% (26378) | HCA / |